Levita Magnetics is revolutionizing minimally invasive surgery with its proprietary Magnetic Surgery® technology. Founded in 2011, the company is committed to enhancing patient outcomes and quality of life by minimizing the footprint of surgery, reducing the number of incisions, and trocars required in procedures, leading to improved cosmetic results. With its innovative platform, the company aims to enable reduced-port surgeries with less visible scars, decreased pain, and faster recovery. The company has recently secured a significant $26.00M Series C investment on 11 August 2022 from notable investors including Carao Ventures, Ballast Capital, and MedTex Ventures. Having garnered clearances for laparoscopic cholecystectomy and bariatric procedures, Levita Magnetics is poised for further expansion and impact within the biotechnology and healthcare industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series C | $26.00M | 3 | Ballast Capital, MedTex Ventures | 11 Aug 2022 |
Convertible Note | Unknown | 1 | 31 Jan 2020 | |
Venture Round | $1.00M | 6 | Alex Seelenberger, Nicolas Luksic +3 | 19 Jul 2019 |
Series B | Unknown | - | 01 Oct 2017 | |
Venture Round | Unknown | - | 01 Aug 2017 |
No recent news or press coverage available for Levita Magnetics.